2010•Chinese Journal of RehabilitationRequires access

Effects of Atorvastatin on Vascular Fibrosis and Connective Tissue Growth Factor in Renovascular Hypertensive rats

Chen Zhi-lon

Open publisher page 0 citations

Abstract

Objective:To investigate the effects of atorvastatin on vascular fibrosis and connective tissue growth factor (CTGF) in renovascular hypertensive (RH) rats. Methods:The following groups of rats were studied: sham group, RH group and atorvastatin (10 mgokg-1od-1)-treated RH group. Systolic blood pressure (SBP) was measured. The mRNA expression of CTGF, FN and ColⅢ was detected by RT-PCR at the 12th week after operation. The expression of CTGF protein was detected by immunohistochemistry. Results: Compared with the normal control group, the mRNA expression of CTGF (P0.01), FN and ColⅢ (P0.05) in RH group was increased in the thoracic aorta, and atorvastatin could significantly inhibit vascular fibrosis and the expression of CTGF (P0.05). Conclusion: Atorvastatin could inhibit the development of vascular fibrosis in RH rats, which was probably related to the decreased expression of CTGF.

About this research paper

What this paper is about

Objective:To investigate the effects of atorvastatin on vascular fibrosis and connective tissue growth factor (CTGF) in renovascular hypertensive (RH) rats. Methods:The following groups of rats were studied: sham group, RH group and atorvastatin (10 mgokg-1od-1)-treated RH group. Systolic blood pressure (SBP) was measured. The mRNA expression of CTGF, FN and ColⅢ was detected by RT-PCR at the 12th week after operation. The expression of CTGF protein was detected by immunohistochemistry. Results: Compared with the normal control group, the mRNA expression of CTGF (P0.01), FN and ColⅢ (P0.05) in RH group was increased in the thoracic aorta, and atorvastatin could significantly inhibit vascular fibrosis and the expression of CTGF (P0.05). Conclusion: Atorvastatin could inhibit the development of vascular fibrosis in RH rats, which was probably related to the decreased expression of CTGF.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To investigate the effects of atorvastatin on vascular fibrosis and connective tissue growth factor (CTGF) in renovascular hypertensive (RH) rats. Methods:The following groups of rats were studied: sham group, RH group and atorvastatin (10 mgokg-1od-1)-treated RH group. Systolic blood pressure (SBP) was measured. The mRNA expression of CTGF, FN and ColⅢ was detected by RT-PCR at the 12th week after operation. The expression of CTGF protein was detected by immunohistochemistry. Results: Compared with the normal control group, the mRNA expression of CTGF (P0.01), FN and ColⅢ (P0.05) in RH group was increased in the thoracic aorta, and atorvastatin could significantly inhibit vascular fibrosis and the expression of CTGF (P0.05). Conclusion: Atorvastatin could inhibit the development of vascular fibrosis in RH rats, which was probably related to the decreased expression of CTGF.

Key concepts: CTGF, Atorvastatin, Connective tissue, Fibrosis, Internal medicine, Medicine, Endocrinology, Growth factor

Related papers

Back to paper searchBrowse research topicsOriginal source
Effects of Atorvastatin on Vascular Fibrosis and Connective Tissue Growth Factor in Renovascular Hypertensive rats — Research Paper | ScholarLens